EUVIMEDEUVIMED entdecken
Crossref

Peripheral Th and NK cells are associated with response to lenvatinib plus PD-1 inhibitor in unresectable hepatocellular carcinoma

Yiping Zou, Zhihong Chen, Zhenrong Chen, Yuanpeng Zhang, Zehao Zheng, Fan Wu, Lianqun Xu, Qiao Li, Ye Lin, Ning Shi, Haosheng Jin

Clinical Immunology · 2023-04 · 249 · 109290

DOI: 10.1016/j.clim.2023.109290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2023-04. Verfasst von Yiping Zou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Clinical Key Specialty Project Foundation, Guangdong Provincial People's Hospital, Guangzhou Municipal Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The value of peripheral blood lymphocyte subpopulations in predicting responses to lenvatinib combination with programmed death-1 (PD-1) inhibitors in unresectable hepatocellular carcinoma (HCC) was investigated. Fifteen patients received objective responses (OR) and sixteen patients had non-objective responses (NOR) were analyzed. The counts of peripheral blood lymphocyte subpopulations from patients were measured before treatment, second (at week 3), and third doses (at week 6) of the PD-1 inhibitor administration, and correlated with responses. Helper T (Th) cells and natural killers (NK) cells were more abundant in the OR group and found to be important predictors of OR in a stepwise multivariate logistic regression analysis. These cutoff values of Th and NK cells could help to distinguish OR from NOR cases accurately and provide clinical benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansImmune Checkpoint InhibitorsKiller Cells, NaturalPhenylurea CompoundsQuinolines

Stichwörter der Autor:innen

Hepatocellular carcinomaLenvatinibLymphocytePD-1 inhibitor

Substanzen

Immune Checkpoint InhibitorslenvatinibPhenylurea CompoundsQuinolines

Autor:innen und Institutionen

  • Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; Tianjin Medical University Cancer Institute and Hospital, Nat…
  • Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; Shantou University Medical College, Shantou, China.
  • Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; Guangdong Cardiovascular Institute, Guangdong Provincial Peop…
  • Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address: shining_doc@163.com.
  • Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address: kinghaos@126.com.

Förderung

  • National Clinical Key Specialty Project Foundation
  • Guangdong Provincial People's Hospital
  • Guangzhou Municipal Science and Technology Project

Zitieren

APA

Zou, Y., Chen, Z., Chen, Z., Zhang, Y., Zheng, Z., Wu, F., Xu, L., Li, Q., Lin, Y., Shi, N., & Jin, H. (2023). Peripheral Th and NK cells are associated with response to lenvatinib plus PD-1 inhibitor in unresectable hepatocellular carcinoma. Clinical Immunology, 249, 109290. https://doi.org/10.1016/j.clim.2023.109290

Vancouver

Zou Y, Chen Z, Chen Z, Zhang Y, Zheng Z, Wu F, et al. Peripheral Th and NK cells are associated with response to lenvatinib plus PD-1 inhibitor in unresectable hepatocellular carcinoma. Clinical Immunology. 2023;249:109290. doi:10.1016/j.clim.2023.109290

BibTeX
@article{Zou2023,
  author = {Zou, Yiping and Chen, Zhihong and Chen, Zhenrong and Zhang, Yuanpeng and Zheng, Zehao and Wu, Fan and Xu, Lianqun and Li, Qiao and Lin, Ye and Shi, Ning and Jin, Haosheng},
  title = {Peripheral Th and NK cells are associated with response to lenvatinib plus PD-1 inhibitor in unresectable hepatocellular carcinoma},
  journal = {Clinical Immunology},
  year = {2023},
  volume = {249},
  pages = {109290},
  doi = {10.1016/j.clim.2023.109290}
}
Kostenlos starten →